Nankai Chemical Company,Limited (4040.T)
JPY 2137.0
(1.71%)
JPY 2137.0
(1.71%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 19.98 Billion | 19.6 Billion | 17.43 Billion | 16.46 Billion |
| Cost of Revenue | 14.48 Billion | 15.09 Billion | 13.3 Billion | 12.59 Billion |
| Gross Profit | 5.5 Billion | 4.5 Billion | 4.12 Billion | 3.86 Billion |
| Operating Expenses | 3.94 Billion | 3.7 Billion | 3.49 Billion | 3.13 Billion |
| Selling, General and Administrative Expenses | 3.94 Billion | 3.7 Billion | 3.38 Billion | 3.13 Billion |
| Research and Development Expenses | 218 Million | 195 Million | 195 Million | 171 Million |
| Other Expenses | -217 Million | 86 Million | 7 Million | 36 Million |
| Cost and Expenses | 18.42 Billion | 18.8 Billion | 16.8 Billion | 15.73 Billion |
| Operating Income | 1.56 Billion | 796 Million | 739 Million | 730 Million |
| Interest Expense | 43 Million | 42 Million | 46 Million | 52 Million |
| Income Tax Expense | 484 Million | 153 Million | -9 Million | -85 Million |
| Earnings before Tax | 1.66 Billion | 663 Million | 463 Million | 69 Million |
| Net Income | 1.15 Billion | 504 Million | 462 Million | 155 Million |
| Earnings Per Share Basic | 586.41 | 391.90 | 359.83 | 82.18 |
| Earnings Per Share Diluted | 574.72 | 391.90 | 359.83 | 82.18 |
| Weighted Average Shares Outstanding | 1.97 Million | 1.28 Million | 1.28 Million | 1.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.01 Million | 1.28 Million | 1.28 Million | 1.88 Million |
| Gross Margin | 0.28 | 0.23 | 0.24 | 0.24 |
| EBIT Margin | 0.13 | 0.10 | 0.09 | 0.10 |
| Profit Margin | 0.06 | 0.03 | 0.03 | 0.01 |
| EBITDA | 2.58 Billion | 1.8 Billion | 1.48 Billion | 1.07 Billion |
| Earnings Before Tax Margin | 0.08 | 0.04 | 0.04 | 0.04 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 4.61 Billion | 5.56 Billion | 19.98 Billion | 5.28 Billion | 4.26 Billion | 4.87 Billion |
| Cost of Revenue | 3.19 Billion | 4.24 Billion | 14.48 Billion | 3.85 Billion | 3.03 Billion | 3.34 Billion |
| Gross Profit | 1.41 Billion | 1.32 Billion | 5.5 Billion | 1.42 Billion | 1.23 Billion | 1.52 Billion |
| Operating Expenses | 1.06 Billion | 1.04 Billion | 3.94 Billion | 1.02 Billion | 911 Million | 957 Million |
| Selling, General and Administrative Expenses | 1.06 Billion | 1.04 Billion | - | 1.02 Billion | 911 Million | 957 Million |
| Research and Development Expenses | - | 218 Million | - | 57 Million | 51 Million | 48 Million |
| Other Expenses | 1 Million | 64 Million | 207 Million | 190 Million | -18 Million | -29 Million |
| Cost and Expenses | 4.25 Billion | 5.29 Billion | 18.42 Billion | 4.88 Billion | 3.94 Billion | 4.3 Billion |
| Operating Income | 355 Million | 275 Million | 1.56 Billion | 398 Million | 320 Million | 571 Million |
| Interest Expense | 12 Million | 11 Million | 43 Million | 11 Million | 10 Million | 11 Million |
| Income Tax Expense | 131 Million | 95 Million | 484 Million | 136 Million | 94 Million | 159 Million |
| Earnings before Tax | 466 Million | 247 Million | 1.66 Billion | 513 Million | 335 Million | 567 Million |
| Net Income | 335 Million | 147 Million | 1.15 Billion | 369 Million | 245 Million | 397 Million |
| Earnings Per Share Basic | 167.39 | 73.84 | - | 186.39 | 123.75 | 203.86 |
| Earnings Per Share Diluted | 165.71 | 70.77 | - | 182.80 | 122.21 | 202.73 |
| Weighted Average Shares Outstanding | 2.02 Million | 2.07 Million | 2.01 Million | 2.01 Million | 2 Million | 1.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.02 Million | 2.07 Million | 2.01 Million | 2.02 Million | 2 Million | 1.95 Million |
| Gross Margin | 0.31 | 0.24 | 0.28 | 0.27 | 0.29 | 0.31 |
| EBIT Margin | 0.13 | 0.06 | - | 0.11 | 0.08 | 0.12 |
| Profit Margin | 0.07 | 0.03 | 0.06 | 0.07 | 0.06 | 0.08 |
| EBITDA | 611.5 Million | 339 Million | - | 574 Million | 321 Million | 590 Million |
| Earnings Before Tax Margin | 0.08 | 0.05 | 0.08 | 0.08 | 0.08 | 0.12 |
GTK
9680
HLBBF
OCLN
BKRIY
DEXSF